Home › Overweight › New York › Rochester
Pag-aaral pangklinika para sa Overweight sa Rochester, NY
Isang pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Rochester. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Nagre-recruitPhase 2
- Rochester Clinical Research /ID# 282484, Rochester
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Nagre-recruitPhase 2
- Rochester Clinical Research, Rochester
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Nagre-recruitPhase 3
- Rochester Clinical Research, LLC, Rochester
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Nagre-recruitPhase 3
- Rochester Clinical Research, LLC, Rochester
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Nagre-recruitPhase 3
- Rochester Clinical Research, Rochester
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Nagre-recruitPhase 3
- Rochester Clinical Research, LLC, Rochester
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Nagre-recruitPhase 3
- Rochester Clinical Research, LLC, Rochester
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Nagre-recruitPhase 2
- Rochester Clinical Research, LLC, Rochester
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Nagre-recruitPhase 2
- Rochester Clinical Research, LLC, Rochester
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Nagre-recruitPhase 3
- Rochester Clinical Research, Rochester
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Nagre-recruitPhase 3
- Kailera Clinical Site, Rochester
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Nagre-recruitPhase 3
- Rochester Clinical Research, Rochester
Impact of Increased Body Mass Index on Adolescent Fixed Orthodontic Treatment. A Prospective Longitudinal Study
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Eastman Institute for Oral Health, University of Rochester, Rochester
Pag-aaral para sa Overweight sa ibang lungsod
- San Antonio, TX34 pag-aaral
- Houston, TX33 pag-aaral
- Chicago, IL28 pag-aaral
- Orlando, FL27 pag-aaral
- Las Vegas, NV23 pag-aaral
- Miami, FL23 pag-aaral
- Atlanta, GA20 pag-aaral
- Dallas, TX20 pag-aaral
- New York City, NY19 pag-aaral
- Jacksonville, FL19 pag-aaral
- Washington, DC19 pag-aaral
- Austin, TX18 pag-aaral
Iba pang pag-aaral sa Rochester
- Acute Myeloid Leukemia16 pag-aaral
- Kanser sa Baga15 pag-aaral
- Kanser sa Suso15 pag-aaral
- Kanser (lahat ng uri)14 pag-aaral
- Obesity14 pag-aaral
- Non-Small Cell Lung Cancer13 pag-aaral
- Kanser sa Prostate10 pag-aaral
- Multiple Myeloma8 pag-aaral
- Metastatic Cancer8 pag-aaral
- Kanser sa Pancreas7 pag-aaral
- Myotonic Dystrophy7 pag-aaral
- Kanser sa Pantog7 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.